Early research (Phase 1)Study completedNCT03673020What this trial is testingPhase 1a Study to Evaluate Immunogenicity of ASV®Who this might be right forSolid Tumor, Adult Agenus Inc. 3
Testing effectiveness (Phase 2)Study completedNCT01285817What this trial is testingA Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.Who this might be right forSurvival Without Progression Assistance Publique Hopitaux De Marseille 79
Early research (Phase 1)Ended earlyNCT02668770What this trial is testingIpilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid MalignanciesWho this might be right forAdvanced CancersMelanoma M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT02100007What this trial is testingME-344 Given in Combination With Hycamtin® in Patients With Solid TumorsWho this might be right forSolid Tumors MEI Pharma, Inc. 46
Testing effectiveness (Phase 2)UnknownNCT02638428What this trial is testingGenomics-Based Target Therapy for Children With Relapsed or Refractory MalignancyWho this might be right forRelapsed Pediatric Solid TumorRefractory Pediatric Solid TumorRelapsed Pediatric AML+1 more Samsung Medical Center 90
Very early researchLooking for participantsNCT06150365What this trial is testingPersonalized KSX01-TCRT in Patients With Advanced Solid TumorsWho this might be right forRefractory Solid TumorsRelapsed Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 12
Early research (Phase 1)Study completedNCT03611595What this trial is testingCabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid TumorsWho this might be right forSolid Tumor Peter Zage 15
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Early research (Phase 1)Looking for participantsNCT07306559What this trial is testingTest How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)Who this might be right forAdvanced Relapsed or Refractory Germ Cell TumoursAdvanced Relapsed or Refractory Endometrial CancerAdvanced Relapsed or Refractory Ovarian Cancer Boehringer Ingelheim 187
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Not applicableStudy completedNCT00923468What this trial is testingPharmacokinetic Studies Participation SurveyWho this might be right forRelapsed Solid TumorsRelapsed LeukemiaRelapsed Brain Tumors National Cancer Institute (NCI) 25
Early research (Phase 1)Active Not RecruitingNCT04606433What this trial is testingPhase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic Leukemia Sichuan Baili Pharmaceutical Co., Ltd. 47
Testing effectiveness (Phase 2)Looking for participantsNCT02332668What this trial is testingPembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Who this might be right forMelanomaLymphomaSolid Tumor+2 more Merck Sharp & Dohme LLC 370
Testing effectiveness (Phase 2)Ended earlyNCT02003092What this trial is testingRX-5902 Treatment of Subjects With Triple Negative Breast CancerWho this might be right forSolid TumorTriple Negative Breast Cancer Rexahn Pharmaceuticals, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT04870944What this trial is testingCBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaWho this might be right forDiffuse Midline Glioma, H3 K27-AlteredMetastatic Malignant Neoplasm in the Central Nervous SystemRecurrent Diffuse Intrinsic Pontine Glioma+7 more Children's Oncology Group 63
Early research (Phase 1)Study completedNCT00339144What this trial is testingStudy of Dasatinib (BMS-354825) in Patients With Solid TumorsWho this might be right forTumors Bristol-Myers Squibb 16
Early research (Phase 1)Ended earlyNCT00003926What this trial is testingAmifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more Masonic Cancer Center, University of Minnesota 13
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Early research (Phase 1)Study completedNCT02390843What this trial is testingSimvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsWho this might be right forRetinoblastomaClear Cell SarcomaRenal Cell Carcinoma+9 more Emory University 13